These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 17952126

  • 1. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
    Buytaert E, Matroule JY, Durinck S, Close P, Kocanova S, Vandenheede JR, de Witte PA, Piette J, Agostinis P.
    Oncogene; 2008 Mar 20; 27(13):1916-29. PubMed ID: 17952126
    [Abstract] [Full Text] [Related]

  • 2. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
    Zupkó I, Kamuhabwa AR, D'Hallewin MA, Baert L, De Witte PA.
    Int J Oncol; 2001 May 20; 18(5):1099-105. PubMed ID: 11295062
    [Abstract] [Full Text] [Related]

  • 3. Role of p38 MAPKs in hypericin photodynamic therapy-induced apoptosis of nasopharyngeal carcinoma cells.
    Chan PS, Koon HK, Wu ZG, Wong RN, Lung ML, Chang CK, Mak NK.
    Photochem Photobiol; 2009 May 20; 85(5):1207-17. PubMed ID: 19496992
    [Abstract] [Full Text] [Related]

  • 4. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin.
    Kamuhabwa AR, Huygens A, Roskams T, De Witte PA.
    Int J Oncol; 2006 Mar 20; 28(3):775-80. PubMed ID: 16465384
    [Abstract] [Full Text] [Related]

  • 5. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells.
    Wang X, Guo Y, Yang S, Wang C, Fu X, Wang J, Mao Y, Zhang J, Li Y.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):847-53. PubMed ID: 20551295
    [Abstract] [Full Text] [Related]

  • 6. Targeted inhibition of p38alpha MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy.
    Hendrickx N, Dewaele M, Buytaert E, Marsboom G, Janssens S, Van Boven M, Vandenheede JR, de Witte P, Agostinis P.
    Biochem Biophys Res Commun; 2005 Nov 25; 337(3):928-35. PubMed ID: 16214108
    [Abstract] [Full Text] [Related]

  • 7. Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy.
    Kocanova S, Buytaert E, Matroule JY, Piette J, Golab J, de Witte P, Agostinis P.
    Apoptosis; 2007 Apr 25; 12(4):731-41. PubMed ID: 17219054
    [Abstract] [Full Text] [Related]

  • 8. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R, Gan YY, Yee KK, Soo KC, Olivo M.
    Int J Mol Med; 2007 Oct 25; 20(4):421-8. PubMed ID: 17786271
    [Abstract] [Full Text] [Related]

  • 9. Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation.
    Huygens A, Kamuhabwa AR, Van Laethem A, Roskams T, Van Cleynenbreugel B, Van Poppel H, Agostinis P, De Witte PA.
    Int J Oncol; 2005 Jun 25; 26(6):1691-7. PubMed ID: 15870887
    [Abstract] [Full Text] [Related]

  • 10. Mitochondrial reactive oxygen species and nitric oxide-mediated cancer cell apoptosis in 2-butylamino-2-demethoxyhypocrellin B photodynamic treatment.
    Lu Z, Tao Y, Zhou Z, Zhang J, Li C, Ou L, Zhao B.
    Free Radic Biol Med; 2006 Nov 15; 41(10):1590-605. PubMed ID: 17045927
    [Abstract] [Full Text] [Related]

  • 11. Melanomas display increased cytoprotection to hypericin-mediated cytotoxicity through the induction of autophagy.
    Davids LM, Kleemann B, Cooper S, Kidson SH.
    Cell Biol Int; 2009 Oct 15; 33(10):1065-72. PubMed ID: 19596456
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of action of phenanthroperylenequinones in photodynamic therapy (review).
    Ali SM, Olivo M.
    Int J Oncol; 2003 Jun 15; 22(6):1181-91. PubMed ID: 12738982
    [Abstract] [Full Text] [Related]

  • 13. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
    Kamuhabwa AA, Huygens A, De Witte PA.
    Int J Oncol; 2003 Nov 15; 23(5):1445-50. PubMed ID: 14532989
    [Abstract] [Full Text] [Related]

  • 14. Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin.
    Du HY, Li Y, Olivo M, Yip GW, Bay BH.
    Oncol Rep; 2006 Dec 15; 16(6):1397-402. PubMed ID: 17089067
    [Abstract] [Full Text] [Related]

  • 15. p38(MAPK)-regulated induction of p62 and NBR1 after photodynamic therapy promotes autophagic clearance of ubiquitin aggregates and reduces reactive oxygen species levels by supporting Nrf2-antioxidant signaling.
    Rubio N, Verrax J, Dewaele M, Verfaillie T, Johansen T, Piette J, Agostinis P.
    Free Radic Biol Med; 2014 Feb 15; 67():292-303. PubMed ID: 24269898
    [Abstract] [Full Text] [Related]

  • 16. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer.
    Du H, Bay BH, Mahendran R, Olivo M.
    Cancer Lett; 2006 Apr 28; 235(2):202-8. PubMed ID: 15935550
    [Abstract] [Full Text] [Related]

  • 17. The multifaceted photocytotoxic profile of hypericin.
    Theodossiou TA, Hothersall JS, De Witte PA, Pantos A, Agostinis P.
    Mol Pharm; 2009 Apr 28; 6(6):1775-89. PubMed ID: 19739671
    [Abstract] [Full Text] [Related]

  • 18. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY, Bay BH, Olivo M.
    Int J Oncol; 2003 May 28; 22(5):1019-24. PubMed ID: 12684667
    [Abstract] [Full Text] [Related]

  • 19. [Role of calcium signal in apoptosis and protective mechanism of colon cancer cell line SW480 in response to 5-aminolevulinic acid-photodynamic therapy].
    Zheng JH, Shi D, Zhao Y, Chen ZL.
    Ai Zheng; 2006 Jun 28; 25(6):683-8. PubMed ID: 16764761
    [Abstract] [Full Text] [Related]

  • 20. Photoactivation of hypericin down-regulates glutathione S-transferase activity in nasopharyngeal cancer cells.
    Du HY, Olivo M, Tan BK, Bay BH.
    Cancer Lett; 2004 Apr 30; 207(2):175-81. PubMed ID: 15072826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.